These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3582071)

  • 1. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up.
    Mammel MC; Fiterman C; Coleman M; Boros SJ
    Dev Pharmacol Ther; 1987; 10(1):1-11. PubMed ID: 3582071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dexamethasone therapy in bronchopulmonary dysplasia].
    Merz U; Kuehl G; Linderkamp O
    Klin Padiatr; 1989; 201(1):11-5. PubMed ID: 2495383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.
    Ballabh P; Kumari J; Krauss AN; Shin JJ; Jain A; Auld PA; Lesser ML; Cunningham-Rundles S
    Pediatrics; 2003 Mar; 111(3):461-8. PubMed ID: 12612222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone in the treatment of bronchopulmonary dysplasia.
    Benini F; Rubaltelli FF; Griffith P; Sala M; Zorzi C
    Acta Paediatr Scand Suppl; 1989; 360():108-12. PubMed ID: 2642245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia.
    Pappagallo M; Abbasi S; Bhutani VK
    Indian J Pediatr; 1998; 65(2):273-82. PubMed ID: 10771973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia.
    Marinelli KA; Burke GS; Herson VC
    J Pediatr; 1997 Apr; 130(4):594-602. PubMed ID: 9108858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.
    Mammel MC; Green TP; Johnson DE; Thompson TR
    Lancet; 1983 Jun; 1(8338):1356-8. PubMed ID: 6134136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression.
    Brundage KL; Mohsini KG; Froese AB; Walker CR; Fisher JT
    Pediatr Pulmonol; 1992 Mar; 12(3):162-9. PubMed ID: 1641273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with successful extubation following the first course of systemic dexamethasone in ventilator-dependent preterm infants with or at risk of developing bronchopulmonary dysplasia.
    O'Connor K; Hurst C; Llewellyn S; Davies M
    Pediatr Pulmonol; 2022 Apr; 57(4):1031-1041. PubMed ID: 34994109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
    Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
    Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
    Shenai JP; Mellen BG; Chytil F
    Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
    Kari MA; Heinonen K; Ikonen RS; Koivisto M; Raivio KO
    Arch Dis Child; 1993 May; 68(5 Spec No):566-9. PubMed ID: 8323356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects and long-term follow-up of corticosteroid therapy in very low birthweight infants with bronchopulmonary dysplasia.
    Ferrara TB; Couser RJ; Hoekstra RE
    J Perinatol; 1990 Jun; 10(2):137-42. PubMed ID: 2358896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dexamethasone in the treatment of bronchopulmonary dysplasia].
    Schrod L; Frauendienst-Egger G; Forgber I; von Stockhausen HB
    Pneumologie; 1991 Nov; 45(11):892-6. PubMed ID: 1762998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of corticosteroids and the outcome of infants with bronchopulmonary dysplasia.
    Mataloun MM; Gibelli MA; Kato AV; Vaz FA; Leone CR
    Rev Hosp Clin Fac Med Sao Paulo; 1999; 54(6):175-80. PubMed ID: 10881064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia.
    Sobel DB; Philip AG
    Pediatrics; 1992 Oct; 90(4):529-33. PubMed ID: 1408504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes.
    Cuna A; Lewis T; Dai H; Nyp M; Truog WE
    Pediatr Pulmonol; 2019 Feb; 54(2):165-170. PubMed ID: 30537393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.